Ikena Oncology, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ikena Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • Ikena Oncology, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 11.5 %, a 20.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 11.5 -2.97 -20.5% Sep 30, 2024
Q2 2024 13.2 -1.72 -11.5% Jun 30, 2024
Q1 2024 13 -5.05 -27.9% Mar 31, 2024
Q4 2023 13.4 -5.66 -29.6% Dec 31, 2023
Q3 2023 14.5 -5.07 -26% Sep 30, 2023
Q2 2023 15 -6.88 -31.5% Jun 30, 2023
Q1 2023 18.1 -5.8 -24.3% Mar 31, 2023
Q4 2022 19.1 -7.45 -28.1% Dec 31, 2022
Q3 2022 19.5 -26.4 -57.4% Sep 30, 2022
Q2 2022 21.8 Jun 30, 2022
Q1 2022 23.9 Mar 31, 2022
Q4 2021 26.6 Dec 31, 2021
Q3 2021 45.9 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.